VEGFA and coronary artery disorder: Moreover, phase I studies evaluating intramyocardial injection of plasmid-encoded VEGF DNA via thoracotomy in patients with end-stage coronary artery disease were associated with improvement of symptoms and blood flow to ischemic territories [27,28,29].